logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Ethylmethylhydroxypyridine malate effect on hepar metabolic function in patients with different functional classes of chronic heart failure

[Original research] [Internal diseases]
Vladimir Kukes; Evgeniya Shih; Anna Zhestovskaia; Ludmila Pavlova; Olga Goroshko;

Activity of CYP3A4 cytochrome Р450 was examined in 90 patients with I–III functional classes of chronic heart failure (CHF) before and after the seven-day intravenous administration of Ethylmethylhydroxypyryridine malate (Ethoxidol) 100 mg/day. There was a statistically significant increase of CYP3A4 cytochrome Р450 activity evaluated by
urinary 6-β-hydroxycortisol/cortisol ratio in patients with I, II and III functional classes of CHF after seven day intravenous administration of 100 mg/day Ethylmethylhydroxypyryridine malate.

Download

References:
1. Kukes V., Sychev D., Ramenskaja V., Savchenko A., Semenov N., Chilova R., Rodchenkov G., Appolonova S., Bubol’c A., Novikov A., Sivkov A., Hadzhieva B. Vrach. – Doctor. 2008;(3):13-19.
2. Luk’janova L. D. Vestnik Ross. Akad. Med. nauk. – Bulletin of the Russian Academy of Medical Sciences. 1999;(3):18-25.
3. Luk’janova L. D. Sovremennye problemy i perspektivy farmakologicheskoj korrekcii gipoksicheskih sostojanij. armakoterapija v nevrologii i psihiatrii; 2002:22-34.
4. Rekomendacii ESC po diagnostike i lecheniju ostroj i hronicheskoj serdechnoj nedostatochnosti (2016) Rabochaja
gruppa po diagnostike i lecheniju ostroj i hronicheskoj serdechnoj nedostatochnosti Evropejskogo Obshhestva
kardiologov (ESC) Pri uchastii: Associacii Serdechnoj Nedostatochnosti (ASN) v sostave ESC. Rossijskij kardiologicheskij
zhurnal. – Russian Cardiology Journal. 2017;1(141):7-81. doi: 10.15829/1560-4071-2017- 1-7-81
5. Smirnov A. V., Krivoruchko B. I. Antigipoksanty v neotlozhnoj medicine. – Anesteziologija i reanimatologija. 1998;(2):50-55.
6. Smirnov V. V., Savchenko A. Ju., Ramenskaja G. V. Biomedicina. – Вiomedicine. 2010;(4):56-60.
7. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic
patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 1992;327:685-691. doi: 10.1056/ NEJM199209033271003
8. Wang T. J. Circulation. 2003;108:977-982.
9. Zuber R. Anzenbacherová E., Anzenbacher P. J. Cell. Mol.
Med. 2002;(6):189-198.

Keywords: chronic heart failure, ethylmethylhydroxypyryridine malate, CYP3A4 of cytochrome Р450 activity


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy